Direct head-to-head trials between retatrutide, tirzepatide, and semaglutide havent been completed
Learn more about how much water to drink on a GLP-1 if you want a deeper breakdown of hydration habits that support treatment
Treat low blood sugar immediately with 15 grams of fast-acting carbohydrates (juice, glucose tablets, or regular soda), then recheck your blood sugar after 15 minutes
Tirzepatide (dual GIP/GLP-1 agonist, not yet formally approved for obesity in the EU): in the SURMOUNT-1 study, resulted in an average weight loss of up to 22.5% at 72 weeks with the 15 mg weekly dose, approaching the effectiveness observed with some bariatric procedures
These findings are based on the results of two recently published clinical trials
While earlier studies on GLP-1 medications and mental health have produced mixed findings, many of those studies were smaller